Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study.
about
Manual lymphatic drainage for lymphedema following breast cancer treatmentConservative interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapyConventional interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapyInterventions to promote energy balance and cancer survivorship: priorities for research and careSystematic review of breast cancer related lymphoedema: making a balanced decision to perform an axillary clearanceLymphatic abnormalities in the normal contralateral arms of subjects with breast cancer-related lymphedema as assessed by near-infrared fluorescent imaging.Treatment related impairments in arm and shoulder in patients with breast cancer: a systematic review.Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study.Lifestyle risk factors associated with arm swelling among women with breast cancer.Prescription and adherence to lymphedema self-care modalities among women with breast cancer-related lymphedemaBreast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management.Proactive approach to lymphedema risk reduction: a prospective studyRisk factors for self-reported arm lymphedema among female breast cancer survivors: a prospective cohort studyObesity or overweight is associated with worse pathological response to neoadjuvant chemotherapy among Chinese women with breast cancerPrevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil.Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery.Weight and weight change following breast cancer: evidence from a prospective, population-based, breast cancer cohort study.An algorithm to identify the development of lymphedema after breast cancer treatment.Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.Novel Mechanisms of Compromised Lymphatic Endothelial Cell Homeostasis in Obesity: The Role of Leptin in Lymphatic Endothelial Cell Tube Formation and ProliferationPatterns of Obesity and Lymph Fluid Level during the First Year of Breast Cancer Treatment: A Prospective StudyBlack breast cancer survivors experience greater upper extremity disabilityComparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology.Risk factors associated with breast cancer-related lymphedema in the WHEL StudyThe effect of prospective monitoring and early physiotherapy intervention on arm morbidity following surgery for breast cancer: a pilot studyRace or Resource? BMI, Race, and Other Social Factors as Risk Factors for Interlimb Differences among Overweight Breast Cancer Survivors with Lymphedema.Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity.Weight management and its role in breast cancer rehabilitation.Breast and gynecologic cancer-related extremity lymphedema: a review of diagnostic modalities and management options.Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer.Diagnosis and treatment of lymphedema after breast cancer: a population-based study.Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care.Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel : Part 1: Definitions, Assessments, Education, and Future Directions.Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study.Strategic recruitment of an ethnically diverse cohort of overweight survivors of breast cancer with lymphedema.Adjuvant taxanes and the development of breast cancer-related arm lymphoedema.Effects of a physical therapy program combined with manual lymphatic drainage on shoulder function, quality of life, lymphedema incidence, and pain in breast cancer patients with axillary web syndrome following axillary dissection.Development of breast cancer-related lymphedema: is it dependent on the patient, the tumor or the treating physicians?Quantitative Lymphoscintigraphy to Predict the Possibility of Lymphedema Development After Breast Cancer Surgery: Retrospective Clinical Study.Acupuncture for breast cancer-related lymphedema: a randomized controlled trial.
P2860
Q24187877-5FE43345-336D-4513-B1CF-768F0051426AQ24188134-401C5EAF-2195-4289-80C5-83BB40CE5B57Q24200611-193887F4-2599-49E4-860E-FE30FAE3B673Q26851370-08291B9E-E920-4F9E-909E-8115B2D2D8BCQ27001564-6DDDCC5F-7BB7-4823-8CB4-06B28AF45455Q30466366-25AA9C06-E16C-4319-8403-DF1C0E998E69Q33590486-98C55FC5-AB52-4A5A-8704-204ACA04F6CAQ33880910-26C1E59D-412B-45B8-8712-7F2FA7AD25DFQ34004915-D03927D2-BE26-44F4-B349-61FBCC30CC55Q34004921-1F64A9D4-DB33-455B-B00A-7146FA5AB630Q34023622-868BDD0B-3266-4BE2-80C7-294AC8FE5DC4Q34175175-27EC7724-EF43-4DC4-AA21-E1167B5A2115Q34304007-894A1ADD-D546-498E-9CB3-C631E9693F71Q34358393-20DF096D-34AC-4EE7-94D7-639C9F4FCC83Q34585025-DBB377B2-4CFC-4233-85A8-AF458F3BB211Q34683635-9BFD1C26-BAE4-40C1-BB9A-9C5C6A075802Q35053866-0CDB3AA2-A49D-49B3-8753-E2F1A01C7B1DQ35185438-2F60E80F-1E5F-4C30-9817-9DF84D4FD68DQ35490056-CF037DE9-19A6-4B92-9824-A62149B20BBFQ36065716-140D5A28-2A79-4139-9698-B4BA45E1F7D8Q36143741-54CFCDDF-F46D-411D-9A24-C6CEAAF7A3E1Q36217990-820EF51E-3290-470C-A9B5-7852E970A7E0Q36587170-2BA9CCB4-74E8-4C2D-B393-0A9F6A550E7EQ36597735-2C5A8CD1-C6FD-4EC0-9A75-0335A0F01A70Q36905679-FE6AE160-5A64-44D9-803F-3F3ACF6C7B65Q37084325-8796426A-53AE-4B13-BCE6-E3AEC2B91DD1Q37180380-11FB36AC-ECE8-438A-BDFF-BDA2920DE074Q37267393-C3B1E9F6-39D9-48EF-9BC8-8FDF1A11A66CQ37366477-894084FD-8D5C-4829-83F1-185D48ED4F32Q37416098-A6499831-ACB7-4B00-8FC3-0B1AB402793BQ37467956-22C21466-5DA5-4B7C-8D09-487E8CE6A0D0Q38001373-F56272D8-7F1B-4C97-93E0-4B66498AB60EQ38648224-7B08415A-1D80-4606-A6B1-B5EFB6469976Q39568660-67543C51-2AC6-4000-9642-4FAAF5E20804Q40053399-4451D0B2-34D5-4085-A7D9-39307F91B414Q40872781-7A6D0CC3-D289-4736-AAAC-406B7AEBB48CQ41145701-76182AA8-8E4A-4019-A6AA-D439B2ABF245Q44149353-B51662A2-BEBF-45F2-B369-36FA6F20D07FQ48200283-D3813D52-CF2D-4E18-826E-20126A4C92CBQ51742517-09FE1221-3F58-40E1-9237-889681AA4E11
P2860
Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Risk factors for lymphedema in ...... hip study: the Pathways Study.
@ast
Risk factors for lymphedema in ...... hip study: the Pathways Study.
@en
Risk factors for lymphedema in ...... hip study: the Pathways Study.
@nl
type
label
Risk factors for lymphedema in ...... hip study: the Pathways Study.
@ast
Risk factors for lymphedema in ...... hip study: the Pathways Study.
@en
Risk factors for lymphedema in ...... hip study: the Pathways Study.
@nl
prefLabel
Risk factors for lymphedema in ...... hip study: the Pathways Study.
@ast
Risk factors for lymphedema in ...... hip study: the Pathways Study.
@en
Risk factors for lymphedema in ...... hip study: the Pathways Study.
@nl
P2093
P2860
P1433
P1476
Risk factors for lymphedema in ...... ship study: the Pathways Study
@en
P2093
Jeanne Darbinian
Marilyn L Kwan
Paula Partee
Rebecca Citron
Susan E Kutner
P2860
P304
P356
10.1001/ARCHSURG.2010.231
P577
2010-11-01T00:00:00Z